Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1289646-72-5

Post Buying Request

1289646-72-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1289646-72-5 Usage

General Description

The chemical compound C28H23Cl2N is a chlorinated derivative of diphenylamine. It is a white crystalline solid that appears as a yellow powder, commonly used as a stabilizer in the production of plastics and rubber products. Its molecular formula indicates the presence of 28 carbon atoms, 23 hydrogen atoms, 2 chlorine atoms, and 1 nitrogen atom in its structure. C28H23Cl2N has a molecular weight of approximately 455.40 g/mol. It is important to handle this substance with care, as it can be harmful if ingested or inhaled, and can cause irritation to the skin and eyes upon contact.

Check Digit Verification of cas no

The CAS Registry Mumber 1289646-72-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,8,9,6,4 and 6 respectively; the second part has 2 digits, 7 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1289646-72:
(9*1)+(8*2)+(7*8)+(6*9)+(5*6)+(4*4)+(3*6)+(2*7)+(1*2)=215
215 % 10 = 5
So 1289646-72-5 is a valid CAS Registry Number.

1289646-72-5Relevant articles and documents

Discovery and development of potent LFA-1/ICAM-1 antagonist SAR 1118 as an ophthalmic solution for treating dry eye

Zhong, Min,Gadek, Thomas R.,Bui, Minna,Shen, Wang,Burnier, John,Barr, Kenneth J.,Hanan, Emily J.,Oslob, Johan D.,Yu, Chul H.,Zhu, Jiang,Arkin, Michelle R.,Evanchik, Marc J.,Flanagan, W. Mike,Hoch, Ute,Hyde, Jennifer,Prabhu, Saileta,Silverman, Jeffrey A.,Wright, Jasmin

, p. 203 - 206 (2012)

LFA-1/ICAM-1 interaction is essential in support of inflammatory and specific T-cell regulated immune responses by mediating cell adhesion, leukocyte extravasation, migration, antigen presentation, formation of immunological synapse, and augmentation of T-cell receptor signaling. The increase of ICAM-1 expression levels in conjunctival epithelial cells and acinar cells was observed in animal models and patients diagnosed with dry eye. Therefore, it has been hypothesized that small molecule LFA-1/ICAM-1 antagonists could be an effective topical treatment for dry eye. In this letter, we describe the discovery of a potent tetrahydroisoquinoline (THIQ)-derived LFA-1/ICAM-1 antagonist (SAR 1118) and its development as an ophthalmic solution for treating dry eye.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1289646-72-5